AbCellera Biologics Inc.
ABCL Healthcare Biotechnology
AbCellera Biologics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.1 million, up 160.6% from fiscal 2024. In the quarter to June 2026, revenue fell 76.3%, EPS fell 50.0% and free cash flow grew 152.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow ABCL
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | |
|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
558.83 | 650.61 | 785.59 | 911.49 | 747.98 | 594.12 | 7.55 | 10.00 |
Receivables |
58.29 | 33.62 | 30.59 | 38.59 | 160.58 | 213.24 | 3.28 | 1.00 |
Other current assets |
111.11 | 67.14 | 55.81 | 75.41 | 21.25 | 5.97 | 1.81 | 3.00 |
Total current assets |
728.23 | 751.37 | 871.99 | 1,025.49 | 929.80 | 813.33 | 12.64 | 15.00 |
Property, Plant, Equpment (Net) |
428.00 | 340.43 | 287.70 | 217.26 | 111.62 | 17.92 | 8.48 | 6.00 |
Long-Term Investments |
62.58 | 82.30 | 65.94 | 72.52 | 50.31 | 19.25 | — | — |
Goodwill and Intangible Assets (Total) |
86.19 | 89.92 | 168.23 | 179.31 | 196.20 | 146.65 | 1.00 | 0.00 |
Long-term assets (Other) |
51.95 | 96.54 | 94.24 | 46.33 | 30.64 | 8.39 | 2.37 | — |
Total non-current assets |
628.72 | 609.18 | 616.11 | 515.42 | 388.77 | 192.21 | 10.85 | — |
Total Assets |
1,356.95 | 1,360.55 | 1,488.09 | 1,540.91 | 1,318.57 | 1,005.54 | 23.49 | — |
Accounts Payable |
50.78 | 55.00 | 49.58 | 52.50 | 32.02 | 20.20 | 2.58 | 2.00 |
Accrued Expenses |
— | — | — | 19.35 | 22.51 | 27.14 | — | — |
Current Part of Debt |
— | — | — | — | — | — | 2.08 | 3.00 |
Current Part of Capital Lease |
— | — | — | — | — | — | — | 0.00 |
Current Part of Taxes to Pay |
— | — | — | 35.68 | 35.68 | 36.15 | — | 0.00 |
Current Revenue (Deferred) |
13.53 | 13.52 | 18.96 | 21.61 | 7.54 | 6.59 | 3.24 | — |
Total current liabilities |
64.31 | 76.61 | 119.01 | 118.32 | 120.68 | 103.49 | 7.90 | 6.00 |
Long Term Debt (Total) |
— | — | — | — | — | — | 1.36 | 1.00 |
Non-current Revenue (Deferred) |
174.45 | 149.89 | 104.11 | 60.32 | 60.76 | 25.89 | 1.34 | 0.00 |
Long Term Tax Liability (Deferred) |
9.12 | 10.05 | 30.61 | 33.18 | 37.37 | 26.16 | — | — |
Minority Interests |
— | — | — | — | — | — | — | 0.00 |
Non-current Liabilities (Other) |
4.77 | 7.17 | 10.82 | 19.14 | 37.62 | 15.77 | — | 0.00 |
Total non-current liabilities |
325.74 | 227.86 | 216.76 | 189.31 | 172.16 | 71.54 | 5.34 | — |
Total liabilities |
390.05 | 304.47 | 335.78 | 307.63 | 292.84 | 175.03 | 13.24 | — |
Additional Paid In Capital |
198.28 | 166.36 | 121.05 | 74.12 | 35.36 | 5.92 | 2.30 | 0.00 |
Preferred Stock (Total) |
— | — | — | — | — | — | 7.55 | 0.00 |
Common Stock (Net) |
802.34 | 777.17 | 753.20 | 734.37 | 722.43 | 710.39 | 5.12 | 0.00 |
Retained Earnings |
(29.48) | 116.93 | 279.79 | 426.19 | 267.67 | 114.20 | (4.72) | (3.00) |
Treasury Stock |
— | — | — | — | — | — | — | 0.00 |
Shareholders Equity (Other) |
— | — | — | — | — | — | — | 0.00 |
Common Equity (Total) |
966.90 | 1,056.08 | 1,152.32 | 1,233.28 | 1,025.73 | 830.51 | 2.71 | 4.00 |
Shareholders Equity (Total) |
966.90 | 1,056.08 | 1,152.32 | 1,233.28 | 1,025.73 | 830.51 | 10.25 | — |
Shareholders Equity and Liabilities (Total) |
1,356.95 | 1,360.55 | 1,488.09 | 1,540.91 | 1,318.57 | 1,005.54 | 23.49 | — |
Shares (Common) |
300.60 | 295.76 | 290.83 | 286.85 | 283.26 | 269.50 | 151.68 | — |
Shareholders Equity (Tangible) |
880.72 | 966.17 | 984.09 | 1,053.97 | 829.53 | 683.86 | 10.25 | — |
Net Debt |
(558.83) | (650.61) | (785.58) | (911.48) | (747.98) | (594.12) | (4.11) | (6.00) |
Total Debt |
— | — | — | 83.00 | 40.00 | 7.00 | 3.44 | 4.00 |